Literature DB >> 23333688

Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes.

Tse-Ya Yu1, Hung-Yuan Li, Yi-Der Jiang, Tien-Jyun Chang, Jung-Nan Wei, Lee-Ming Chuang.   

Abstract

BACKGROUND: We conducted a cohort study to determine if proteinuria predicts cancer-related mortality in type 2 diabetic subjects.
METHODS: Between July 1996 and June 2003, we enrolled 646 type 2 diabetic subjects. Participants were followed-up until December 31, 2008. The vital status was ascertained by linking records with computerized death certificates in Taiwan.
RESULTS: During a median follow-up of 10.4 years, 158 subjects had died, including 59 from cancers. Subjects with proteinuria had a hazard ratio (HR) of 2.77 (95% CI 1.82-4.21) for all-cause mortality and 1.99 (95% CI 1.00-3.94) for cancer-related mortality after adjustment for demographic factors and medical conditions. Specifically, proteinuria showed a trend of increased colon cancer death. The presence of proteinuria significantly improved the predictive ability of cancer-related mortality (increase in concordance statistics or area under the ROC curve=0.03). Patients with both proteinuria and estimated glomerular filtration rate <60 ml/min per 1.73 m² showed higher HR for all-cause mortality than patients with proteinuria only (adjusted HRs (95% CI), 4.01 (2.42-6.67) vs. 2.69 (1.51-4.79), both p<0.01).
CONCLUSIONS: Proteinuria can predict 10-year all-cause and cancer-related mortalities independently in type 2 diabetic subjects, over and above the established risk factors associated with type 2 diabetes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333688     DOI: 10.1016/j.jdiacomp.2012.11.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  4 in total

1.  Dipstick proteinuria and all-cause mortality among the general population.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2018-06-05       Impact factor: 2.801

2.  THE AUTHORS REPLY.

Authors:  Yejin Mok; Shoshana H Ballew; Yingying Sang; Josef Coresh; Corinne E Joshu; Elizabeth A Platz; Kunihiro Matsushita
Journal:  Am J Epidemiol       Date:  2021-05-04       Impact factor: 4.897

3.  History of lower-limb complications and risk of cancer death in people with type 2 diabetes.

Authors:  Kamel Mohammedi; Stephen Harrap; Giuseppe Mancia; Michel Marre; Neil Poulter; John Chalmers; Mark Woodward
Journal:  Cardiovasc Diabetol       Date:  2021-01-04       Impact factor: 9.951

4.  Cancer mortality in a population-based cohort of American Indians - The strong heart study.

Authors:  Dorothy A Rhoades; John Farley; Stephen M Schwartz; Kimberly M Malloy; Wenyu Wang; Lyle G Best; Ying Zhang; Tauqeer Ali; Fawn Yeh; Everett R Rhoades; Elisa Lee; Barbara V Howard
Journal:  Cancer Epidemiol       Date:  2021-07-19       Impact factor: 2.890

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.